<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>江苏金殳 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-01T11:26:43+08:00</updated>
  <subtitle>致力于仿制药、创新药的研发，核心团队近十几年投身于药理毒理、药学和临床注册研究。公司全体员工以改善人类健康问题为己任，努力做出高质量、价格低、疗效好和安全性高的药品，创造制药企业的社会价值，实现制药人的人生价值。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>如何建立cQMS？(一)</title>
    <updated>2021-01-01T04:36:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/YntmFx6avthERx0AzFk4nA</id>
    <link href="https://mp.weixin.qq.com/s/YntmFx6avthERx0AzFk4nA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021，元旦快乐！</title>
    <updated>2021-01-01T04:36:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/b7MC1VIDrfLQ8HkU0AXAPg</id>
    <link href="https://mp.weixin.qq.com/s/b7MC1VIDrfLQ8HkU0AXAPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>12月31日，CDE发布了19条通知和通告！</title>
    <updated>2021-01-01T04:36:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/mity9aRZHzLu7Ce6m9qroQ</id>
    <link href="https://mp.weixin.qq.com/s/mity9aRZHzLu7Ce6m9qroQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>他山之石—政策引导的仿制药变革（日本篇）</title>
    <updated>2020-12-20T22:05:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/sY_LmNLQwwBqVBIFnGcXPg</id>
    <link href="https://mp.weixin.qq.com/s/sY_LmNLQwwBqVBIFnGcXPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Merry Christmas | 江苏金殳陪你一起过圣诞节~</title>
    <updated>2020-12-20T22:05:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/8TSlg_Ck9paUY4Z0UK5Ukg</id>
    <link href="https://mp.weixin.qq.com/s/8TSlg_Ck9paUY4Z0UK5Ukg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>法规分享||CDE发布《经口吸入制剂仿制药生物等效性研究指导原则》</title>
    <updated>2020-12-20T22:05:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/qCww0jT3IlrWsbNoObQteg</id>
    <link href="https://mp.weixin.qq.com/s/qCww0jT3IlrWsbNoObQteg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>法规分享||CDE发布《年龄相关性黄斑变性治疗药物临床研究技术指导原则》</title>
    <updated>2020-12-20T22:05:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/jcmFolv6_38Tqb84a7z2Ew</id>
    <link href="https://mp.weixin.qq.com/s/jcmFolv6_38Tqb84a7z2Ew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>法规分享||CDE发布《儿科用药临床药理学研究指导原则（征求意见稿）》</title>
    <updated>2020-12-20T22:05:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/ZskU02u65C1VBJDPl9t6kQ</id>
    <link href="https://mp.weixin.qq.com/s/ZskU02u65C1VBJDPl9t6kQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新药研发热点</title>
    <updated>2020-12-14T10:30:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/6bF2j31NSX_A2cqCp19qVQ</id>
    <link href="https://mp.weixin.qq.com/s/6bF2j31NSX_A2cqCp19qVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>法规分享||CDE发布《人源性干细胞及其衍生细胞治疗产品临床试验技术指导原则（征求意见稿）》</title>
    <updated>2020-12-14T10:30:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/Y7pQTzmZlGe5X0fR2bdiNA</id>
    <link href="https://mp.weixin.qq.com/s/Y7pQTzmZlGe5X0fR2bdiNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>法规分享||CDE发布《晚期肝细胞癌临床试验终点技术指导原则（征求意见稿）》</title>
    <updated>2020-12-14T10:30:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/xnfKs5EVyEwiTqPfhCpbkQ</id>
    <link href="https://mp.weixin.qq.com/s/xnfKs5EVyEwiTqPfhCpbkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>法规分享||CDE发布《抗肿瘤药临床试验影像终点程序标准技术指导原则（征求意见稿）》</title>
    <updated>2020-12-14T10:30:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/TOwsbMBfISgT_EoULr7jzA</id>
    <link href="https://mp.weixin.qq.com/s/TOwsbMBfISgT_EoULr7jzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>嘿，MAH，你了解药物警戒体系吗</title>
    <updated>2020-12-07T01:07:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/ImIPz4xVfJ6o0J780cX4sA</id>
    <link href="https://mp.weixin.qq.com/s/ImIPz4xVfJ6o0J780cX4sA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>法规分享||《药物警戒质量管理规范（征求意见稿）》</title>
    <updated>2020-12-07T01:07:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/_ILafTEBD99j3mwhdss-Jg</id>
    <link href="https://mp.weixin.qq.com/s/_ILafTEBD99j3mwhdss-Jg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>法规分享||《个例药品不良反应收集和报告指导原则》</title>
    <updated>2020-12-07T01:07:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/JDKBlvfkHMA-P-kyEeCE9Q</id>
    <link href="https://mp.weixin.qq.com/s/JDKBlvfkHMA-P-kyEeCE9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>法规分享||《药品上市许可持有人直接报告不良反应》</title>
    <updated>2020-12-07T01:07:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/975QJC5k5mHevWmWlaZWuA</id>
    <link href="https://mp.weixin.qq.com/s/975QJC5k5mHevWmWlaZWuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>疫情与新规背景下对基于风险的监查的认识</title>
    <updated>2020-12-02T13:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/6bkOm1m1rC6dbpZZUpZMgg</id>
    <link href="https://mp.weixin.qq.com/s/6bkOm1m1rC6dbpZZUpZMgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《药品附条件批准上市技术指导原则（试行）》的通知</title>
    <updated>2020-12-02T13:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/_FrnnEPthEwiJxpL2pcYmg</id>
    <link href="https://mp.weixin.qq.com/s/_FrnnEPthEwiJxpL2pcYmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《疫苗临床试验抗体分析方法研究技术指导原则（征求意见稿）》的通知</title>
    <updated>2020-12-02T13:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/cuniiJnpkI4XOMUGmrFS6A</id>
    <link href="https://mp.weixin.qq.com/s/cuniiJnpkI4XOMUGmrFS6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《GnRH激动剂用于晚期前列腺癌临床试验设计指导原则》的通告</title>
    <updated>2020-12-02T13:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/KjVj-BKXORqInbEUCbH5TA</id>
    <link href="https://mp.weixin.qq.com/s/KjVj-BKXORqInbEUCbH5TA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>